Antibodies under a microscope

PX-TA1026

Navicixizumab Biosimilar – Anti-DLL4 mAb – Research Grade

Description

Navicixizumab Biosimilar - Anti-DLL4 mAb - Research Grade

Target

DLL4

Target Alias Name

Navicixizumab/Navicixizumab/DLL4/anti-DLL4

Isotype/Mimetic

IgG2Kappa (bispecific)

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression